Cerebellar Ataxia Benefitted by 5-Hydroxytryptophan
Levorotatory 5-hydroxytryptophan (10 mg/kg/day) was found to benefit patients with various inherited or acquired cerebellar ataxias in a long-term randomized, double-blind study at the Hopital Neurologique, Alexis Carrel Faculty of Medicine, Lyon, France.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1989-03-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/3447 |